HY8931

· Newsoara Biopharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HY8931, covering 2026-03-11 to 2026-03-11. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Safety, Tolerability and Pharmacokinetics of HY8931 in Healthy Adult Participants [Phase 1]